7-hydroxy-2-n,n-dipropylaminotetralin and u-91356
7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with u-91356 in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bonifazi, A; Burzynski, C; Donthamsetti, P; Free, RB; Janowsky, A; Javitch, JA; Keck, TM; Kumar, V; Michino, M; Newman, AH; Schweppe, C; Shi, L; Sibley, DR; Zou, MF | 1 |
Bergstrom, DA; Gonzalez, AM; Huang, KX; Kreiss, DS; Sibley, DR; Walters, JR | 1 |
Other Studies
2 other study(ies) available for 7-hydroxy-2-n,n-dipropylaminotetralin and u-91356
Article | Year |
---|---|
Novel Analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D2/D3 Receptor Agonist Selectivity.
Topics: Animals; Benzimidazoles; Binding Sites; Chemistry Techniques, Synthetic; CHO Cells; Cricetulus; Humans; Ligands; Models, Molecular; Molecular Dynamics Simulation; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; Structure-Activity Relationship | 2016 |
Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities.
Topics: Aminoquinolines; Animals; Apomorphine; Azepines; Benzothiazoles; Binding, Competitive; CHO Cells; Cricetinae; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Imidazoles; Male; Neurons; Phenethylamines; Piperidines; Pramipexole; Quinolines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Structure-Activity Relationship; Substantia Nigra; Tetrahydronaphthalenes; Thiazoles; Thiophenes; Transfection | 1995 |